Literature DB >> 30628664

Stathmin gene silencing suppresses proliferation, migration and invasion of gastric cancer cells via AKT/sCLU and STAT3 signaling.

Feng Shu1, Xiaoqin Zou1, Huan Tuo1, Sha She1, Juan Huang1, Hong Ren1, Huaidong Hu1, Shifang Peng1, Jiandong Wang1, Yixuan Yang1.   

Abstract

Globally, gastric cancer is the fifth most common malignancy, with high rates of incidence and mortality. The high mortality rate and poor prognosis of gastric cancer are closely associated with its profound invasiveness, high incidence of metastasis, rapid proliferation, and high rate of recurrence. Previous studies have confirmed that stathmin (STMN) has an important role in the occurrence, development and prognosis of gastric cancer. However, the detailed mechanisms by which STMN affects these processes remain unclear. The aim of the present study was to determine how STMN promotes invasion, migration and proliferation in gastric cancer tumor cells. The results of immunohistochemistry indicated that STMN is overexpressed in stomach neoplasm tissues, and that it is associated with migration, invasion, proliferation and anti‑apoptotic states of gastric cancer cells. The secretory proteins of gastric cancer cells with or without STMN knockdown were further analyzed using the isobaric tags for relative and absolute quantitation method to identify differentially expressed proteins verified by reverse transcription‑quantitative polymerase chain reaction and western blot analysis. Inhibition of STMN decreases the levels of clusterin, cystatin C and matrix metalloproteinases, followed by inhibiting the protein kinase B and signal transducer and activation of transcription activation. These findings suggest that STMN could be a promising therapeutic target for gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30628664     DOI: 10.3892/ijo.2019.4674

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  [Dihydromyricetin inhibits proliferation and migration of gastric cancer cells through regulating Akt/STAT3 signaling pathways and HMGB1 expression].

Authors:  Shengnan Wang; Fei Ge; Tianyu Cai; Shimei Qi; Zhilin Qi
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

Review 2.  The role and function of CLU in cancer biology and therapy.

Authors:  Yefei Zhang; Xiang Lv; Liming Chen; Yan Liu
Journal:  Clin Exp Med       Date:  2022-09-13       Impact factor: 5.057

3.  Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme.

Authors:  Xian-Mei Wen; Tao Luo; Yi Jiang; Li-Hong Wang; Ying Luo; Qian Chen; Kaidi Yang; Ye Yuan; Chunhua Luo; Xiang Zhang; Ze-Xuan Yan; Wen-Juan Fu; Yu-Huan Tan; Qin Niu; Jing-Fang Xiao; Lu Chen; Jiao Wang; Jia-Feng Huang; You-Hong Cui; Xia Zhang; Yan Wang; Xiu-Wu Bian
Journal:  Lab Invest       Date:  2020-01-16       Impact factor: 5.662

4.  Dermal Fibroblast Migration and Proliferation Upon Wounding or Lipopolysaccharide Exposure is Mediated by Stathmin.

Authors:  Ruiyan Cen; Liqun Wang; Yongqing He; Chenda Yue; Yang Tan; Lingfei Li; Xia Lei
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

5.  Evaluation of CSTB and DMBT1 expression in saliva of gastric cancer patients and controls.

Authors:  Maryam Koopaie; Marjan Ghafourian; Soheila Manifar; Shima Younespour; Mansour Davoudi; Sajad Kolahdooz; Mohammad Shirkhoda
Journal:  BMC Cancer       Date:  2022-04-30       Impact factor: 4.638

Review 6.  Emerging role of microtubule-associated proteins on cancer metastasis.

Authors:  Onsurang Wattanathamsan; Varisa Pongrakhananon
Journal:  Front Pharmacol       Date:  2022-09-14       Impact factor: 5.988

Review 7.  STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Sima Orouei; Vahideh Zarrin; Ebrahim Rahmani Moghadam; Amirhossein Zabolian; Shima Mohammadi; Kiavash Hushmandi; Yashar Gharehaghajlou; Pooyan Makvandi; Masoud Najafi; Reza Mohammadinejad
Journal:  Biology (Basel)       Date:  2020-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.